ACC latest: Lilly, Merck, Pfizer, Novartis and more unveil key data

Tracy Staton

You missed the American College of Cardiology meeting. That's OK. The most newsworthy research coming out of the meeting is gathered right here, with almost every Big Pharma in attendance.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS